Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
A 57-year-old man with IgG, ISS stage II multiple myeloma with normal cytogenetics was treated with vincristine/adriamycin/ dexamethasone induction followed by autologous hematopoietic stem cell transplantation and achieved a very good partial response. The patient relapsed 4.5 years later and received bortezomib/ dexamethasone treatment, which conferred a very good partial response once again. After 3 years, his M protein level showed a rapid increase to 7.9 g/dl for a month. He also developed anemia, thrombocytopenia (white blood cell count, 5600/l; hemoglobin, 7.3 g/dl; platelet count, 9000/l), acute kidney injury, and acute liver failure. Relapse of multiple myeloma was confirmed by bone marrow biopsy, which showed 55.8% clonal plasma cells with complex karyotype abnormality including addition of 1q21, and fluorescence in situ hybridization revealed deletion of p53. Notably, neutrophils harboring prominent Auer rods were found in his bone marrow. Several pseudo- Pelger-Huet anomaly cells were observed, however myeloblasts were only 0.5%; there was no myeloblast with Auer rods. Also mild dyserythropoiesis and few abnormal megakaryocytes were observed (Figure 1)..
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi